http://orcid.org/0000-0002-0025-7426
References
- Cheng AC, Currie BJ. Melioidosis: epidemiology, pathophysiology, and management. Clin Microbiol Rev. 2005;18(2):383–416.
- Sanchez-Villamil JI, Torres AG. Melioidosis in Mexico, Central America, and the Caribbean. Tropicalmed. 2018;3(1):24.
- Lipsitz R, Garges S, Aurigemma R, et al. Workshop on treatment of and postexposure prophylaxis for Burkholderia pseudomallei and B. mallei Infection, 2010. Emerg Infect Dis. 2012;18(12):e2.
- Merritt AJ, Inglis TJJ. The Role of Climate in the Epidemiology of Melioidosis. Curr Trop Med Rep. 2017;4(4):185–191.
- Wiersinga WJ, Currie BJ, Peacock SJ. Melioidosis. N Engl J Med. 2012;367(11):1035–1044.
- The Centers for Disease Control and Prevention. Melioidosis. 2012; https://www.cdc.gov/melioidosis/index.html.
- Kingston CW. Chronic or latent melioidosis. Med J Aust. 1971;2(12):618–621.
- Meumann EM, Cheng AC, Ward L, Currie BJ. Clinical features and epidemiology of melioidosis pneumonia: results from a 21-year study and review of the literature. Clin Infect Dis. 2012;54(3):362–369.
- Ip M, Osterberg LG, Chau PY, Raffin TA. Pulmonary melioidosis. Chest 1995;108(5):1420–1424.
- Chan HP, Yip HS. Mediastinal Lymphadenopathy: Melioidosis Mimicking Tuberculosis. Tropmedhealth. 2015;43(2):93–94.
- Lowe P, Haswell H, Lewis K. Use of various common isolation media to evaluate the new VITEK 2 colorimetric GN Card for identification of Burkholderia pseudomallei. J Clin Microbiol. 2006;44(3):854–856.